Answers are grounded in this paper and cite their sources.
CD44 is an important CSC marker in CRC patients. Furthermore, CRC patients with high expression of CD44v2 have a poorer prognosis than patients with other CD44 variants.
No takes yet. Share an insight, caveat, or question.
Ozawa et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: